Anthony Bergmann
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 29SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 24,10011,223 held (−68%) | $30.38 | $732K | -74.2% |
| Jun 24SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 50011,223 held (−4%) | $30.00 | $15K | -73.9% |
| Jun 24SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 40011,223 held (−3%) | $30.00 | $12K | -73.9% |
| May 4SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 25,0008,223 held (−75%) | $31.70 | $792K | -75.3% |
| Apr 1SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 25,0008,223 held (−75%) | $30.13 | $753K | -74.0% |
- Sell
CFO Anthony Bergmann sold $732K of CAPR at $30.38 — cuts the stake by 68%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Anthony Bergmann sold $15K of CAPR at $30.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Anthony Bergmann sold $12K of CAPR at $30.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Anthony Bergmann sold $792K of CAPR at $31.70 — cuts the stake by 75%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Anthony Bergmann sold $753K of CAPR at $30.13 — cuts the stake by 75%; pre-scheduled 10b5-1 plan sale.